Qualitative Concept
FDA Authorizes Novavax’s Updated COVID-19 Vaccine for Emergency Use
Novavax COVID-19 Vaccine, FDA Authorization, Emergency Use, Protein-Based Vaccine, JN.1 Variant
Recursion’s Phase 2 Trial for Cerebral Cavernous Malformation Shows Limited Efficacy Despite Meeting Safety Goals
Recursion Pharmaceuticals, Phase 2 trial, cerebral cavernous malformation (CCM), REC-994, safety and tolerability, efficacy data, FDA meeting
ProKidney Suspends One Phase 3 CKD Cell Therapy Trial Deemed Surplus for FDA Approval
ProKidney, CKD, cell therapy, Phase 3 trial, FDA approval
Novavax’s Updated COVID-19 Vaccine Receives FDA Emergency Use Authorization
Novavax, COVID-19 vaccine, FDA, Emergency Use Authorization, protein-based vaccine, JN.1 variant
FDA Approves Emergent’s ACAM2000 Vaccine for Mpox Prevention, Pledges 50,000 Doses to Affected Regions
FDA approval, Emergent BioSolutions, ACAM2000 vaccine, mpox prevention, vaccine donation, global health response
FDA Approves Revolutionary Re-Expandable Stent for Young Children
FDA approval, re-expandable stent, young children, congenital heart disease, minimally invasive procedures
FDA Approves Illumina’s TruSight Oncology Comprehensive Test for Pan-Cancer Companion Diagnostics
FDA approval, Illumina, TruSight Oncology Comprehensive, pan-cancer, companion diagnostics, NTRK gene fusions, RET fusion-positive NSCLC, targeted therapies, precision oncology.
Pfizer Unveils PfizerForAll, a Direct-to-Consumer Platform for Migraine, Flu, and COVID-19 Products
PfizerForAll, Direct-to-Consumer, Migraine, Flu, COVID-19, Telehealth, Prescription Services, Vaccination Scheduling, Savings Programs
FDA Limits Use of Invivyd’s COVID-19 Prophylactic as New Variants Dominate
Invivyd, COVID-19, Pemgarda, Emergency Use Authorization, FDA, Immunocompromised, Variants
Roche’s PiaSky Receives European Approval for Rare Blood Disorder Treatment
Roche, PiaSky, Crovalimab, Paroxysmal Nocturnal Hemoglobinuria (PNH), Rare Blood Disorder, European Approval